CW July 2003
Volume 12Issue Number 7 July 2003 ISSN 10593802 Can Liver Cancer be Prevented by COX-2 Inhibitors?Cyclooxygenase-2, an enzyme protein complex that is present in most tissue can favor cancerous growth by several mechanisms. Selective inhibitors of this enzyme that are classified under nonsteroidal anti-inflammatory drugs (NSAIDs) are found to prevent early-stage hepatocellular cancer.
Go to Previous Page Go to Next Page Source & Additional Reading Koga, H. Hepatocellular Carcinoma: Is there a Potential for Chemoprevention Using Cyclooxigenase-2 Inhibitors? Cancer, June 25, 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
